Assessment of use of antibiotics in Covid-19 patients
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2022/01/039784
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients of either sex having positive RTPCR of SARS-CoV-2
covid positive patients initiated on antibiotics within 48hrs of hospital admission
Exclusion Criteria
Patients with a negative RTPCR report
Patients with Covid severity classified as Mild
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain antibiotic efficacy in CTRI/2022/01/039784 Coronavirus disease patients?
How do antibiotic treatment outcomes compare to standard-of-care in South Indian tertiary care Coronavirus disease patients?
Which biomarkers correlate with antibiotic response in CTRI/2022/01/039784 observational study of Coronavirus disease patients?
What adverse events are associated with antibiotic use in CTRI/2022/01/039784 Coronavirus disease cohort?
How do combination antibiotic strategies impact SARS-CoV-2 infection management in CTRI/2022/01/039784 study?